Results 1 to 10 of about 18,271 (248)
The Effect of Intravenous Dextrose Administration on Postoperative Nausea and Vomiting: Systematic Review and Meta-Analysis with Trial Sequential Analysis [PDF]
MedicinaBackground and Objectives: Intravenous dextrose administration is a potential nonpharmacological adjunct for preventing postoperative nausea and vomiting (PONV); however, its efficacy and optimal timing remain unclear.
Jae Hyuk Choi +3 more
doaj +2 more sources
Management of chemotherapy induced emesis [PDF]
Archive of Oncology, 2004 Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently.
Roila Fausto
doaj +3 more sources
BMC Cancer, 2021 Background Among patients with colorectal cancer (CRC) treated with oxaliplatin (L-OHP)-based chemotherapy, delayed chemotherapy-induced nausea and vomiting (CINV) have not been well controlled.
Mototsugu Shimokawa +8 more
doaj +1 more source
Frontiers in Oncology, 2021 IntroductionThe aim of this study is to rigorously review the efficacy and safety of olanzapine in chemotherapy-induced nausea and vomiting (CINV) settings including (1) at 5- and 10-mg doses, and (2) the setting of highly emetogenic chemotherapy (HEC ...
Dong-Yang Wang +3 more
doaj +1 more source
Prophylaxis of postoperative nausea and vomiting with combination of ondansetron and dexametasone in urology: Prophylaxis of postoperative nausea and vomiting [PDF]
Serbian Journal of Anesthesia and Intensive Therapy, 2016 Introduction: Postoperative nausea and vomiting is an unpleasant, distressing and exhausting experience for patients. There are inconsistent findings concerning approach to the management of PONV and disagreement as to whether prophylaxis of PONV should ...
Gvozdić Branka +2 more
doaj +1 more source
Frontiers in Oncology, 2020 Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific evidence proves its detrimental impact on a patient's quality of life (QoL), treatment compliance ...
Ashok K. Vaid +10 more
doaj +1 more source
Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children
Children, 2020 This study was conducted to investigate the safety and efficacy of olanzapine for high and moderate emetogenic chemotherapy in children and young adults.
So Rae Lee +3 more
doaj +1 more source
Brazilian Journal of Oncology, 2022 Objectives: This study aimed to characterize the clinical profile and the factors that predispose chemotherapy-induced nausea and vomiting (CINV) in the acute and delayed phases. Methods: A retrospective cohort study
Ariádne Sousa Albuquerque +5 more
doaj +1 more source
Rotatory nystagmus after granisetron administration
Saudi Journal of Emergency Medicine, 2021 Background: Granisetron is a popular antiemetic medication used in the emergency department to control nausea and vomiting with an excellent side effect profile among adults and pediatric, in both healthy and oncology patients.
Abdulelah Shafiq Abualfraj +3 more
doaj +1 more source
Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial [PDF]
The Korean Journal of Internal Medicine, 2023 Background/Aims We compared the efficacy of the granisetron transdermal system (GTS) with that of ondansetron for controlling chemotherapy-induced nausea and vomiting (CINV) in patients treated with highly emetogenic chemotherapy (HEC).
Der Sheng Sun +7 more
doaj +1 more source